About
Medisafe is a comprehensive patient engagement platform built for the full pharmaceutical treatment ecosystem—serving pharma brands, healthcare providers, and patients simultaneously. For pharmaceutical companies, Medisafe deploys branded digital drug companions for each therapy in a portfolio, giving brands a direct channel into patients' daily lives beyond the prescription. Commercial and medical teams gain access to real-world adherence insights, IQVIA-validated ROI measurement, and seamless integration with existing hub, copay, and patient services programs. For healthcare providers, the platform delivers real-time behavioral signals on patient adherence between visits, automated alerts when patients show discontinuation risk, therapy-specific education automation, and AI-driven patient check-ins that reduce administrative overhead. For patients, Medisafe provides an intuitive mobile experience for managing multiple medications, personalized reminders that adapt to individual routines, condition-specific educational content, and caregiver tools enabling family members to support a loved one's treatment plan. Backed by NIH-published research and peer-reviewed outcomes data, Medisafe has demonstrated adherence rate increases of over 20% in clinical studies. With 25+ pharma brand partners spanning 150+ countries, it is one of the most validated patient engagement platforms in the industry. Whether a pharma team is launching a new cardiovascular drug or supporting patients through breast cancer therapy, Medisafe provides the infrastructure to activate, engage, and retain patients at scale.
Key Features
- Branded Digital Drug Companions: Deploy therapy-specific digital companions for each brand in a pharma portfolio to engage patients throughout the full treatment journey.
- Real-World Adherence Insights: Access behavioral adherence analytics and real-world data to inform commercial strategy, medical decisions, and patient support program design.
- Personalized Adaptive Reminders: Medication reminders that learn and adapt to each patient's individual routine, improving consistency and long-term adherence.
- Provider Adherence Monitoring & Alerts: Real-time behavioral signals and automated discontinuation-risk alerts help providers proactively intervene before patients abandon therapy.
- IQVIA-Validated ROI Measurement: Peer-reviewed and IQVIA-validated outcomes data enables pharma teams to demonstrate program ROI with credible, publishable evidence.
Use Cases
- Pharmaceutical brands launching new therapies who need a branded digital companion to activate and retain patients post-prescription
- Pharma commercial and medical affairs teams seeking real-world adherence data and validated ROI metrics across their brand portfolio
- Healthcare providers monitoring patient medication adherence between clinical visits and identifying at-risk patients before they discontinue therapy
- Patients managing complex multi-drug regimens who need personalized, adaptive reminders and condition-specific educational content
- Caregivers supporting a family member through chronic illness treatment using Medisafe's dedicated caregiver management tools
Pros
- Clinically Validated Outcomes: NIH-published research and IQVIA validation back up adherence improvements of 20%+, giving pharma stakeholders confidence in the platform's efficacy.
- Massive Global Scale: 13M+ patients supported across 150+ countries with 25+ pharma partners demonstrates proven real-world adoption and operational reliability.
- Full Ecosystem Coverage: Serves pharma brands, providers, and patients in one unified platform with seamless integration into existing hub, copay, and patient services programs.
- High Return on Investment: Up to 50x ROI validated by IQVIA makes the business case straightforward for pharma commercial and patient services teams.
Cons
- Enterprise-Oriented Access: Designed primarily for pharmaceutical companies and large health systems; smaller clinics or independent practitioners may find it difficult to access or afford.
- Opaque Public Pricing: No pricing is publicly listed—pharma brands must request a demo, which can lengthen the sales and evaluation cycle.
- Pharma-First Architecture: Core platform prioritizes pharma brand partnerships, which may limit the depth of customization available to standalone provider deployments.
Frequently Asked Questions
What is Medisafe and who is it for?
Medisafe is a digital patient engagement platform designed for pharmaceutical brands, healthcare providers, and patients. It helps pharma teams extend support beyond the prescription, enables providers to monitor adherence between visits, and gives patients intuitive tools to manage their medications.
How many patients has Medisafe supported?
Medisafe has supported over 13 million patients across more than 150 countries, working with 25+ pharmaceutical brand partners and delivering up to 50x validated ROI.
Is Medisafe backed by clinical research?
Yes. Medisafe is IQVIA-validated and has NIH-published research demonstrating medication adherence rate improvements of over 20% in clinical studies.
How does Medisafe integrate with existing pharma infrastructure?
Medisafe integrates seamlessly with existing hub programs, copay programs, and patient services programs, allowing brands to extend patient engagement without replacing their current commercial infrastructure.
Can healthcare providers use Medisafe independently of a pharma partnership?
Yes. Medisafe offers a dedicated solution for providers that monitors patient adherence between visits, sends discontinuation-risk alerts, automates therapy-specific education, and reduces administrative burden through automated patient check-ins.
